Abstract
Abnormal electrophysiological activity in the striatum, which receives dense innervation from the cerebral cortex, is believed to set the stage for the behavioral phenotype observed in Huntington's disease (HD), a neurodegenerative condition caused by mutation of the huntingtin (mhtt) protein. However, cortical involvement is far from clear. To determine whether abnormal striatal processing can be explained by mhtt alone (cell-autonomous model) or by mhtt in the corticostriatal projection cell-cell interaction model, we used BACHD/Emx1-Cre (BE) mice, a conditional HD model in which full-length mhtt is genetically reduced in cortical output neurons, including those that project to the striatum. Animals were assessed beginning at 20 weeks of age for at least the next 40 weeks, a range over which presymptomatic BACHD mice become symptomatic. Both open-field and nest-building behavior deteriorated progressively in BACHD mice relative to both BE and wild-type (WT) mice. Neuronal activity patterns in the dorsal striatum, which receives input from the primary motor cortex (M1), followed a similar age progression because BACHD activity changed more rapidly than either BE or WT mice. However, in the M1, BE neuronal activity differed sig...Continue Reading
Citations
Oct 27, 2010·PloS One·Carmela GiampàFrancesca Romana Fusco
Aug 8, 2015·PloS One·Antonella CardinaleFrancesca R Fusco
Jul 26, 2016·Frontiers in Human Neuroscience·Kendra D Bunner, George V Rebec
Sep 8, 2016·Proceedings of the National Academy of Sciences of the United States of America·Xiaobei ZhaoWilliam C Mobley
Dec 17, 2016·Journal of Huntington's Disease·Claudia Rangel-Barajas, George V Rebec
Feb 22, 2018·CNS Neuroscience & Therapeutics·George V Rebec
Oct 13, 2018·CNS Neuroscience & Therapeutics·Ana María Estrada-SánchezCarlos Cepeda
Jan 10, 2019·Human Molecular Genetics·Terri L PetkauBlair R Leavitt
Jul 30, 2019·Journal of Neuroscience Research·Carlos CepedaHarry V Vinters
Sep 19, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi Creus-Muncunill, Michelle E Ehrlich
Apr 18, 2020·PLoS Computational Biology·Adam PonziJames Kozloski
Nov 26, 2019·Cerebral Cortex·Elissa J DonzisMichael S Levine
May 1, 2019·Scientific Reports·Johanna BurgoldIrina Dudanova
Aug 17, 2016·Brain Pathology·Mar PuigdellívolEsther Pérez-Navarro
Mar 16, 2017·Brain Structure & Function·Aman Asif-MalikTodor V Gerdjikov
Jul 10, 2019·Annual Review of Neuroscience·C Frank BennettDon W Cleveland
Nov 7, 2019·Journal of Neurophysiology·Ana María Estrada-SánchezGeorge V Rebec
Apr 6, 2018·Nucleic Acid Therapeutics·Willeke M C van Roon-MomSusanne T de Bot
Jul 25, 2018·Current Protocols in Neuroscience·Claudia Rangel-Barajas, George V Rebec
Jun 28, 2018·BMC Biology·Mandi E SchmidtMichael R Hayden
Nov 10, 2017·Cerebral Cortex·Andrea Ruiz-CalvoManuel Guzmán
May 17, 2019·Journal of Neurochemistry·Amy I Smith-DijakLynn A Raymond
Jun 4, 2019·Frontiers in Cellular Neuroscience·Amy I Smith-DijakLynn A Raymond
Apr 21, 2020·Journal of Huntington's Disease·Caodu BurenLynn A Raymond
Nov 18, 2020·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Carlos Cepeda, Michael S Levine
Dec 18, 2020·Neuropathology and Applied Neurobiology·Rachel Y CheongÅsa Petersén
Nov 11, 2017·Current Opinion in Neurobiology·Matthew B Veldman, X William Yang
Jul 19, 2021·Neurobiology of Disease·Justin L ShobeMichael S Levine
Sep 2, 2021·Journal of Neurophysiology·Katerina D OikonomouMichael S Levine